Table 1. Demographic and clinical characteristics.
| Characteristics | Value in total patients (n = 59) |
|---|---|
| Age, mean±SD | 66.5 ±15.0 |
| Male, n (%) | 43 (73) |
| APACHE II. mean±SD | 8.3±3.9 |
| Charlson Score. mean±SD | 3.2±2.0 |
| Cancer, n (%) | 12 (20) |
| Fragile patients (CFS >4). n (%) | 9 (15) |
| BMI, mean±SD | 27.6±4.5 |
| Support | |
| Non-invasive ventilation/high-flow nasal cannula, n (%) | 46 (78) |
| Days of the cannula, median (IQR) | 3.5 (2-6) |
| Mechanical ventilation, n (%) | 38 (64) |
| Days of MV. median (IQR) | 12 (9.25-19.75) |
| ECMO, n (%) | 1 (2) |
| Haemodialysis, n (%) | 9 (15) |
| Neuromuscular blocking agents, n (%) | 35 (59) |
| Days of neuromuscular blocking agents, median (IQR) | 8 (5-10) |
| Days from diagnosis to LUS, median (IQR) | 5 (3.5-9) |
| Length of ICU stay, days, median (IQR) | 12 (8.5-20.5) |
| Length of hospital stay, days, median (IQR) | 20 (13.5-28.5) |
| ICU mortality, n (%) | 32 (54) |
| Hospital mortality, n (%) | 32 (54) |
Abbreviations: CFS = Clinical Frailty Scale; BMI = body mass index; APACHE = Acute Physiology and Chronic Health Evaluation; ECMO = extracorporeal membrane oxygenation; ICU = intensive care unit; SD = standard deviation; IQR = interquartile range.